Table 2 Demographic and clinical characteristics by the patient’s final eGFR category

Number of males

13 (15%)^a

18 (33%)

74 (29%)^b

a < b (0.01)

Current age, mean ± SD

59 ± 11^c

56 ± 13^d

48 ± 21^e

c > e (0.0001); d > e (0.007)

Treatment with antihypertensive agents before declining to eGFR < 60 mL/min/1.73 m²

38 (45%)^f

22 (40%)

72 (28%)^g

f > g (0.005)

Diabetes

21 (25%)

18 (33%)

50 (20%)

–

Treatment with l-thyroxine

 Males

4 (31%)^h

2 (11%)

5 (7%)ⁱ

h > i (0.03)

 Females

32 (45%)

14 (38%)

68 (38%)

 Total

36 (43%)^j

16 (29%)

73 (29%)^k

l > m (0.02)

Circulating thyroid antibodies

 Males

4 (31%)^l

2 (11%)

6 (8%)^m

n > o (0.04)

 Females

29 (41%)

8 (22%)

53 (29%)

–

 Total

33 (39%)ⁿ

10 (18%)

59 (23%)^o

p > q (0.005)